openPR Logo
Press release

Surge in Pharmaceutical Demand Propels Growth Of Small-Molecule CMO/CDMO Market: A Key Factor Shaping the Future of the Small Molecule CMO/CDMO Market in 2025

Surge in Pharmaceutical Demand Propels Growth

Surge in Pharmaceutical Demand Propels Growth

"What combination of drivers is leading to accelerated growth in the small molecule cmo/cdmo market?
Advancements in the pharmaceutical sector are likely to stimulate the expansion of the small-molecule CMO/CDMO market in the near future. The pharmaceutical industry, consisting of the invention, development, and production of drugs by public and private sectors, utilizes small-molecule CMO/CDMO to delegate various operations such as the creation, manufacturing, and packaging of small-molecule drugs. This results in reduced expenses, saved time, and efficient processes for pharmaceutical corporations. For example, the Government of Canada reported in August 2024 that in 2022 domestic exports in the pharmaceutical industry increased to 9.59 billion USD (12.79 billion CAD) from 10.71 billion CAD in 2021. Furthermore, imports also heightened, arriving at 30.21 billion CAD compared to 26.63 billion CAD in 2021. Hence, the surging demand for pharmaceuticals is spearheading the evolution of the small-molecule CMO/CDMO market.

Get Your Small Molecule CMO/CDMO Market Report Here:
https://www.thebusinessresearchcompany.com/report/small-molecule-cmo-or-cdmo-global-market-report

What is the projected compound annual growth rate (CAGR) of the small molecule cmo/cdmo market from 2025 to 2034, and what factors influence it?
Over recent years, the market size of the small molecule CMO/CDMO has seen substantial growth. It is set to rise from $50.58 billion in 2024 to $54.58 billion in 2025 with a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to factors such as government support, cost-effective solutions, increasing complexities in drug development, industry consolidation, and a focus on core competencies.

The market size of CMO/CDMO for small molecules is anticipated to witness robust growth in the upcoming years, escalating to $73.3 billion in 2029 with a compound annual growth rate (CAGR) of 7.7%. The predicted growth in this period can be credited to an increase in drug pipelines, global expansion of pharmaceutical operations, the need for adaptable manufacturing, expertise in regulatory compliance, and the convergence of biopharmaceuticals. The forecast period is also likely to observe major trends such as sustainable and eco-friendly manufacturing methods, heightened collaboration and partnerships, tailored medicine and specialized therapies, the growth of virtual and transition-to-reality companies, incorporation of digital technologies, and quick response manufacturing.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13733&type=smp

How are the latest trends influencing the growth of the small molecule cmo/cdmo market?
Key players in the small-molecule CMO/CDMO market are focusing on advanced technologies like the cutting-edge small-molecule platform in Shanghai to bolster their CDMO offerings. This progressive small-molecule platform is at the heart of technological advancements aimed at developing and producing small-molecule medications, as well as producing pharmaceutical compounds that are safer, more effective, and more efficiently produced. For example, Porton Pharma Solutions Ltd., a pharmaceutical firm based in China, unveiled a state-of-the-art small-molecule platform in Shanghai in June 2023, enhancing its CDMO services. This innovative platform integrates the latest technologies and methods to improve the complete lifecycle of small molecule drugs, providing a comprehensive solution offering end-to-end capabilities, flexibility, availability and digital transformation.

What are the major segments of the small molecule cmo/cdmo market and their role in driving growth?
The small molecule CMO/CDMO market covered in this report is segmented -

1) By Product: Small Molecule Drug Product, Small Molecule API
2) By Stage Type: Clinical, Commercial, Preclinical
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Cardiovascular Disease, Respiratory Disorders, Metabolic Disorders, Other Therapeutics
4) By Application: Cardiovascular, Oncology, Diabetes, Immunological Disorders

Subsegments:
1) By Small Molecule Drug Product: Solid Dosage Forms (Tablets, Capsules), Liquid Dosage Forms (Injectables, Solutions), Topical Dosage Forms
2) By Small Molecule API (Active Pharmaceutical Ingredient): Generic APIs, Branded APIs, Custom Synthesis APIs

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13733

North America was the largest region in the small molecule CMO/CDMO market in 2024. The regions covered in the small molecule CMO/CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the small molecule cmo/cdmo market?
Major companies operating in the small molecule CMO/CDMO market report are Patheon NV (Thermo Fisher Scientific), GlaxoSmithKline, Johnson Matthey PLC, Lonza Group Ltd., WuXi AppTec, Catalent Inc., Aurobindo Pharma, Fareva, Aesica Pharmaceuticals Limited, Siegfried holdings AG, Recipharm AB, Jubilant Life Sciences Limited, Almac Group, Piramal Pharma Solutions, Oxford Chemicals Inc., Syngene International Limited, Novasep, Pfizer CentreOne, GVK Biosciences, ChemPartner, Avid Bioservices Inc., Dishman Carbogen Amcis Ltd., ProChem Inc., Metrics Contract Services

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13733&type=smp

What Is Covered In The Small Molecule CMO/CDMO Global Market Report?

•Market Size Forecast: Examine the small molecule cmo/cdmo market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the small molecule cmo/cdmo market for a structured understanding.
•Key Players Overview: Analyze major players in the small molecule cmo/cdmo market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the small molecule cmo/cdmo market.
•Segment Contributions: Evaluate how different segments drive overall growth in the small molecule cmo/cdmo market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the small molecule cmo/cdmo market.
•Industry Challenges: Identify potential risks and obstacles affecting the small molecule cmo/cdmo market.
•Competitive Landscape: Review strategic developments in the small molecule cmo/cdmo market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surge in Pharmaceutical Demand Propels Growth Of Small-Molecule CMO/CDMO Market: A Key Factor Shaping the Future of the Small Molecule CMO/CDMO Market in 2025 here

News-ID: 3921012 • Views:

More Releases from The Business research company

Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by 2029
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025? Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billion by 2029
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Rheology Modifiers Industry? There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analysis Report
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025? In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growth at 7.1% CAGR Forecast
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports. What is the Projected Market Size of the Pharmaceutical Intermediates Industry? There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound

All 5 Releases


More Releases for CDMO

Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Inhalation CDMO Market Size During the Forecast Period? In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size? The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications. The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for